Cubist Systematic Strategies, LLC Cytokinetics Inc Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 44,100 shares of CYTK stock, worth $2.41 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

44,100

Previous 47,300 6.77%

Holding current value

$2.41 Million

Previous $2.56 Million 9.13%

% of portfolio

0.01%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$63.75 - $108.06 $2.39 Million - $4.05 Million	-37,459 Reduced 43.53%	48,604 $3.41 Million
Q4 2023 Feb 14, 2024	BUY	$26.88 - $83.49 $2.31 Million - $7.19 Million	86,063 New	86,063 $7.19 Million
Q4 2022 Feb 14, 2023	SELL	$35.77 - $51.11 $318,209 - $454,674	-8,896 Reduced 93.74%	594 $27,000
Q3 2022 Nov 14, 2022	SELL	$38.54 - $54.52 $282,613 - $399,795	-7,333 Reduced 43.59%	9,490 $460,000
Q2 2022 Aug 15, 2022	BUY	$33.93 - $48.92 $447,740 - $645,548	13,196 Added 363.83%	16,823 $661,000
Q1 2022 May 16, 2022	SELL	$29.74 - $46.0 $3.04 Million - $4.7 Million	-102,224 Reduced 96.57%	3,627 $134,000
Q4 2021 Feb 14, 2022	BUY	$34.35 - $46.38 $1.73 Million - $2.33 Million	50,327 Added 90.64%	105,851 $4.83 Million
Q3 2021 Nov 15, 2021	BUY	$18.54 - $35.74 $202,178 - $389,744	10,905 Added 24.44%	55,524 $1.98 Million
Q2 2021 Aug 16, 2021	SELL	$19.79 - $26.99 $732,546 - $999,061	-37,016 Reduced 45.34%	44,619 $883,000
Q1 2021 May 17, 2021	BUY	$18.57 - $25.68 $1.33 Million - $1.84 Million	71,714 Added 722.85%	81,635 $1.9 Million
Q4 2020 Feb 16, 2021	SELL	$15.26 - $28.61 $89,011 - $166,882	-5,833 Reduced 37.03%	9,921 $206,000
Q3 2020 Nov 16, 2020	SELL	$20.58 - $28.96 $739,377 - $1.04 Million	-35,927 Reduced 69.52%	15,754 $341,000
Q2 2020 Aug 14, 2020	BUY	$11.15 - $24.64 $495,773 - $1.1 Million	44,464 Added 616.1%	51,681 $1.22 Million
Q1 2020 May 15, 2020	BUY	$8.75 - $16.3 $36,041 - $67,139	4,119 Added 132.96%	7,217 $85,000
Q4 2019 Feb 14, 2020	SELL	$7.95 - $11.84 $106,681 - $158,880	-13,419 Reduced 81.24%	3,098 $33,000
Q3 2019 Nov 14, 2019	SELL	$10.82 - $14.25 $155,991 - $205,442	-14,417 Reduced 46.61%	16,517 $188,000
Q2 2019 Aug 14, 2019	BUY	$7.95 - $11.25 $245,925 - $348,007	30,934 New	30,934 $348,000
Q2 2018 Aug 14, 2018	SELL	$6.9 - $9.9 $70,124 - $100,613	-10,163 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$7.2 - $10.05 $73,173 - $102,138	10,163 New	10,163 $73,000

Others Institutions Holding CYTK

# of Institutions

410

Shares Held

125M

Call Options Held

4.6M

Put Options Held

2.43M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $5.15B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Cytokinetics Inc Transaction History